Cargando…
Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer
BACKGROUND: Heat shock protein-90 alpha (HSP90α) is more abundant in non-small-cell lung cancer (NSCLC) patients than in control individuals. However, whether it can reflect chemotherapy efficacy remains unknown. This study aimed to investigate the association of HSP90α with chemotherapy in advanced...
Autores principales: | Zhong, Bo, Shen, Juxin, Zhang, Chunyi, Zhou, Guozhong, Yu, Yuefang, Qin, E, Tang, Jixian, Wu, Dongping, Liang, Xiaochao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805245/ https://www.ncbi.nlm.nih.gov/pubmed/33419959 http://dx.doi.org/10.12659/MSM.924778 |
Ejemplares similares
-
Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development
por: Wei, Wene, et al.
Publicado: (2021) -
A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
por: Liu, Wei, et al.
Publicado: (2019) -
Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics
por: Han, Yueting, et al.
Publicado: (2021) -
Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression
por: Zhao, Zhengwei, et al.
Publicado: (2010) -
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)